Skip to main content
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · ORMP ISIN · US68403P2039 LEI · 5299006K52ZIIGQJ6R84 TA Manufacturing
Filings indexed 1,576 across all filing types
Latest filing 2025-04-28 Regulatory Filings
Country US United States of America
Listing TA ORMP

About Oramed Pharmaceuticals Inc.

https://www.oramed.com

Oramed Pharmaceuticals Inc. is a clinical-stage company focused on developing oral drug delivery systems for medications that are typically administered via injection. The company's core technology is its proprietary Protein Oral Delivery (POD™) platform, which is designed to protect therapeutic proteins from enzymatic degradation in the gastrointestinal tract and enhance their absorption into the bloodstream. Oramed's lead product candidate is an oral insulin capsule (ORMD-0801) for the treatment of diabetes. The company's pipeline also includes an oral GLP-1 analog capsule (ORMD-0901) for type 2 diabetes. Oramed aims to improve patient compliance, comfort, and therapeutic outcomes by converting injectable treatments into oral formulations.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings
2025-04-28 English
Form 10K For the Fiscal Year Ended December 31, 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'FORM 10-K' and 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934'. It includes a table of contents covering business, risk factors, management's discussion and analysis (MD&A), and financial statements for the fiscal year ended December 31, 2024. This matches the definition of a 10-K Annual Report. FY 2024
2025-04-09 English
Form 10K For the Fiscal Year Ended December 31, 2024
Report Publication Announcement Classification · 100% confidence The document is a short notification (1876 characters) from the Israel Securities Authority (MAGNA system) that explicitly states 'Attached hereto is a report on Form 10K'. Per the 'MENU VS MEAL' rule, this is an announcement of a report rather than the report itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-04-09 English
ANNUAL REPORT
Annual Report FY 2024
2025-03-27 English
CURRENT REPORT
Regulatory Filings
2025-03-03 English
CURRENT REPORT
Regulatory Filings
2025-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.